Table 1 Distribution of comorbidities between the groups
Multimorbidity | |||||
|---|---|---|---|---|---|
Comorbidity | No (n = 46) | Yes (n = 98) | p-value | Missing data | System |
Cancer | 0 (0%) | 2 (1.39%) | 1 | 0 | Cancer |
Stroke (CVA/TIA) | 2 (1.39%) | 10 (6.94%) | 0.339 | 0 | Cardiovascular |
Hypertension | 0 (0%) | 17 (11.81%) | 0.001 | 0 | Cardiovascular |
Angina/MI | 13 (9.03%) | 71 (49.31%) | <0.001 | 0 | Cardiovascular |
Hyperlipidemia | 2 (1.39%) | 6 (4.17%) | 1 | 0 | Cardiovascular |
Heart failure | 1 (0.69%) | 17 (11.81%) | 0.013 | 0 | Cardiovascular |
Extracardiac arteriopathy | 0 (0%) | 11 (7.64%) | 0.017 | 0 | Cardiovascular |
Pulmonary hypertension | 0 (0%) | 1 (0.69%) | 1 | 0 | Cardiovascular |
Ulcerative colitis | 0 (0%) | 1 (0.69%) | 1 | 0 | Digestive |
Liver disease | 0 (0%) | 2 (1.39%) | 1 | 0 | Digestive |
Diabetes | 4 (2.78%) | 43 (29.86%) | <0.001 | 0 | Metabolic and endocrine |
Obesity (BMI > 32) | 4 (2.78%) | 34 (23.61%) | 0.001 | 0 | Metabolic and endocrine |
Arthritis | 0 (0%) | 4 (2.78%) | 0.306 | 0 | Musculoskeletal |
Osteoporosis | 0 (0%) | 1 (0.69%) | 1 | 0 | Musculoskeletal |
Neurological disease | 0 (0%) | 1 (0.69%) | 1 | 0 | Neurological |
Chronic obstructive pulmonary disease | 1 (0.69%) | 21 (14.58%) | 0.002 | 0 | Respiratory |
Asthma | 0 (0%) | 5 (3.47%) | 0.177 | 0 | Respiratory |
Renal disease | 0 (0%) | 8 (5.56%) | 0.055 | 0 | Urogenital |
Anaemia | 2 (1.39%) | 28 (19.44%) | 0.001 | 0 | Hematological |
